Synthetic Biologics, Inc. (SYN)
EBITDA Growth
54.92%
TTM · Period ending:
SYN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported54.92%period ending
Latest reported54.92%period ending
SYN TTM EBITDA YoY % (-69.23% → 54.92%)
Year-over-year change
High-resolution chart · PNG
SYN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -32.312% | |
| -4.4177% | |
| 6.3361% | |
| 6.7797% | |
| -9.6183% | |
| -20.4839% | |
| -42.0744% | |
| -54.2484% | |
| -47.5225% | |
| -87.8788% | |
| -54.8485% | |
| -75.1908% | |
| -238.9313% | |
| -126.0274% | |
| -69.2308% |